Patient Controlled Injectors Market Size, Share, Growth Report 2030

Patient Controlled Injectors Market Size And Industry Analysis

The global Patient Controlled Injectors market, which was estimated at about 2,969 (USD Million) in 2019 and is predicted to accrue earnings worth 6,579 (USD Million) by 2026, is set to record a CAGR of nearly over 12.1% during 2020-2026. The report offers valuation and analysis of Patient Controlled Injectors market on a global as well as regional level. The study offers a comprehensive assessment of the industry competition, limitations, sales estimates, avenues, current & emerging trends, and industry-validated market data. The report offers historical data from 2016 to 2019 along with a forecast from 2020 to 2026 based on value (USD Million).

Patient Controlled Injectors Market: An Overview

Patient controlled injector is the breakthrough in injection administration. The medical device helps in fulfilling the unmet requirements of patients as it offers comfort and ease as compared to any other medical equipment. Moreover, the device is ergonomically created and helps in patient in improving self-care, thereby making it easier for the patients in effectively handling & administering the medicines at a prescribed period. Apart from this, the medical device is a subcutaneous drug delivery tool adhering to the patient body along with helping in inoculating huge volumes of medicine.

Request Free Sample

Patient Controlled Injectors Market: Growth Drivers

Escalating occurrence of chronic ailments such as autoimmune diseases, cancer, and blood ailments resulting in need for elongate duration of treatment will prompt the growth of patient controlled injectors industry over the assessment period. In addition to this, utility of patient controlled injectors has assisted in mitigating risks of contamination, needle stick injuries, and reducing medical errors caused as a result of parenteral mode of medicine administration through injection. This, in turn, will promulgate the expansion of patient controlled injectors industry over the upcoming years. Breakthroughs in pharma sector resulting in launching of new drug therapies for treating severe disorders will translate into massive demand for patient controlled injectors across the healthcare industry over 2020-2026. Apparently, patient controlled injector provides efficient target drug delivery along with long-term medicine residence to affected regions of heart systems, thereby enhancing the popularity of the product in the recent years.

Report Scope:

North America To Make Notable Contributions Towards Overall Market Share By 2026

The regional market growth over 2020-2026 is due to surge in the chronic ailment occurrence requiring patient controlled injectors for inoculating medicines. In addition to this, presence of major participants profiled in the study will drive the regional market trends.

Key participants profiled in the study are Gerresheimer AG, scPharmaceuticals Inc., United Therapeutics Corporation, Westbourne Medical Limited, Enable Injections, Johnson and Johnson Services, Inc., F. Hoffmann-La Roche Ltd., BD, and Ypsomed AG.

The global Patient Controlled Injectors Market is segmented as follows:

By Application:

• Cancer Treatment
• Auto-immune Treatment
• Blood Disorders Treatment

By Product:

• Electronic Wearable Injectors
• Mechanical Wearable Injectors
• Infusion Pumps

By Distribution Channel:

• Hospital Pharmacies
• Retail Pharmacies
• Mail Order Pharmacies

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa